Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Hepatitis A and CYP3A4[original query] |
---|
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. International journal of cancer. Journal international du cancer 2003 Apr 104 (3): 310-7. Silvestri Laura, Sonzogni Laura, De Silvestri Annalisa, Gritti Chiara, Foti Luciana, Zavaglia Claudio, Leveri Michela, Cividini Agostino, Mondelli Mario U, Civardi Emilio, Silini Enrico |
Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. Pharmacogenetics 2004 Oct 14 (10): 691-700. Wojnowski Leszek, Turner Paul C, Pedersen Bonnie, Hustert Elisabeth, Brockmöller Jürgen, Mendy Maimuna, Whittle Hilton C, Kirk Greg, Wild Christopher |
CYP3A4*18 polymorphisms and anti-hepatitis A virus seroprevalence. Hepato-gastroenterology 0 58 (110-111): 1725-9. Ahmad Fazlina, Che Hamzah Nor Aizal, Mustaffa Nazri, Hua Gan Si |
Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects. Drugs in R&D 2017 12 18 (1): 55-65. Garimella Tushar, Tao Xiaolu, Sims Karen, Chang Yi-Ting, Rana Jignasa, Myers Elsa, Wind-Rotolo Megan, Bhatnagar Rahul, Eley Timothy, LaCreta Frank, AbuTarif Mal |
Clinical and genetic determinants of nevirapine plasma trough concentration. SAGE open medicine 2018 6 2050312118780861. Giacomelli Andrea, Rusconi Stefano, Falvella Felicia Stefania, Oreni Maria Letizia, Cattaneo Dario, Cozzi Valeria, Renisi Giulia, Monge Elisa, Cheli Stefania, Clementi Emilio, Riva Agostino, Galli Massimo, Ridolfo Anna Li |
Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C. PloS one 2019 14 (7): e0219022. Kato Keizo, Shimada Noritomo, Atsukawa Masanori, Abe Hiroshi, Itokawa Norio, Matsumoto Yoshihiro, Agata Rie, Tsubota Akihi |
ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients. Arhiv za higijenu rada i toksikologiju 2020 Dec 71 (4): 353-358. Sutlovi? Davorka, Klju?evi? Ċ½eljko, Kuret Sen |
- Page last reviewed:Feb 1, 2024
- Content source: